Endocrine Essentials for Primary Care - St. Louis

St. Louis, MO US

The Endocrine Society brings top-quality clinical updates to your area with Endocrine Essentials Live. This regional series features two programs designed for both professional endocrinologists and for primary care physicians treating endocrine-related diseases.

To claim CME

  • This form is for the Endocrine Essentials for Primary Care meeting in St. Louis, MO on September 27, 2014
  • To evaluate this meeting and claim CME, click "Take Course" to the right

Target Audience

The third year of this regional series will focus on diabetes and obesity, along with appropriate screening of male hypogonadism. The program is geared towards internists, general practitioners, diabetes educators, and other primary care providers.

Learning Objectives

Upon completion of this educational activity, learners will be able to:


  • Identify the clinical and behavioral barriers to achieving weight loss and preventing weight gain in overweight and obese patients
  • Explain the clinical benefits of losing 5% to 10% of excess body weight
  • Explore how newly-approved and emerging weight- loss drugs may be appropriately integrated into a weight-loss program
  • Discuss the clinical data on new pharmaceutical treatment options for obesity
  • Recognize the behavioral approaches to obesity management that are most impactful in practice
  • Define medically significant weight loss and its impact on glycemic parameters
  • Select appropriate medical therapy options for the co-management of diabetes and obesity


  • Explain the role new agents have in assisting current therapeutic challenges
  • Evaluate clinical practice guidelines on diabetes and management of comorbidities and predict how these will evolve in light of new data and clinical experience
  • Compare and critique current glycemia algorithms and discuss the place for new therapies within them
  • Recognize the progression of beta-cell dysfunction in the pathophysiology of T2DM
  • Employ appropriate techniques to achieve and maintain normoglycemia in in-patients
  • Recognize when a patient would benefit from starting basal insulin
  • Explain the fundamentals of team-based care and how to implement when starting and titrating basal insulin
  • Assess the benefits to starting insulin in a patient with poorly controlled diabetes
  • Explain to patients the need for mealtime insulin

Androgen Deficiency

  • Summarize the discussions of the validity of low testosterone
  • Perform appropriate evaluation of symptomatic men to determine if they are androgen deficient
  • Explain the rationale behind key accountability and quality improvement measures in the diagnosis and management of men with androgen deficiency

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Systems-based Practice
Topic Area: 
Diabetes and Glucose Metabolism
General Endocrinology
Men’s Health
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Level 3B (Learning: Procedural Knowledge (Knows How))
Activity summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credits
  • 5.00 CME Certificate of Participation
Course opens: 
Course expires: 
Sheraton St. Louis City Center
400 South 14th Street
St. Louis, MO 63103
United States

Daniel Bessesen, MD – University of Colorado

George Bray, MD – Pennington Biomedical Research Institute

Enrico Cagliero, MD – Massachusetts General Hospital

Michael Irwig, MD – George Washington University

Christopher Sorli, MD, PhD – Billings Clinic


The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

Daniel H. Bessesen, MD: DSMB Member, Enteromedics

George Bray, MD, MACP, MACE: Advisor, Medifast, Inc.; Speaker, Herbalife International of America, Inc., Vivus, Inc.
Christopher Sorli, MD, PhD: Advisor and Speaker, Eli Lilly, Novo Nordisk; Speaker, AstraZeneca, Bristol-Myers Squibb, Janssen

The following faculty reported no relevant financial relationships: Enrico Cagliero, MD; Michael Irwig, MD

The Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

Available Credit

  • 5.00 AMA PRA Category 1 Credits
  • 5.00 CME Certificate of Participation